Warning: Potential Pancreatic Risks Linked to GLP-1 Weight Loss Injections Monday, November 24, 2025 glp1 tirzepatide semaglutide pancreatitis sideeffects weightloss nhs mhra medicationsafety yellowcard GLP-1 receptor agonists, such as tirzepatide (Mounjaro) and semaglutide (Wegovy), are popular injectable medications prescribed to support weight loss by reducing appetite and increasing feelings of fullness. Typically … Read More
Understanding Type 3c Diabetes: A Lesser-Known But Serious Condition Sunday, May 25, 2025 diabetes pancreas type3c pancreatitis pancreaticcancer cysticfibrosis haemochromatosis insulin diagnosis treatment While most people are familiar with type 1 and type 2 diabetes, there is another form called type 3c diabetes that often flies under the radar and is frequently misdiagnosed. This condition accounts for up to 9% of diabetes … Read More